EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The prevalence of HIV resistance mutations and their influence on the shedding of HIV‐1 into peritoneal dialysis effluent

Teboho Mooko iD, Feziwe Busiswa Bisiwe, Perpertual Chikobvu, Molefi Daniel Morobadi, Thabiso Rafaki Petrus Mofokeng, Martin Munene Nyaga, Gabre Kemp, Dominique Goedhals, Kwazi Celani Zwakele Ndlovu

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Teboho Mooko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Viral Load. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thuthuka National Research Foundation (NRF), Bill and Melinda Gates Foundation (BMGF), CSIR-DSI Inter-bursary Support Programme (IBS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV drug resistance mutations (HIVDRMs) are important determinants of therapeutic effects and outcomes even in end‐stage kidney failure (ESKF) people living with HIV (PLWHIV). This study evaluated the prevalence of HIVDRMs and their effect on the shedding of HIV‐1 into peritoneal dialysis (PD) effluents. This cross‐sectional study of PLWHIV and having ESKF and managed with antiretroviral therapy (ART) and PD, collected enrolled patients’ demographic information, clinical and laboratory data, and sequenced HIV‐1 RNA in unsuppressed plasma and PD effluent samples. HIV viral load and HIVDRMs were determined using qualitative polymerase chain reaction (qPCR) and Stanford University HIVDRM Database, respectively. There were 60 participants recruited with a median age of 43.0 (interquartile range [IQR], 38.0–47) years and were predominantly on abacavir (88.3%), lamivudine (98.3%), and efavirenz (70%) for a median duration of 8 (IQR, 5–11) years. Among participants with detectable HIV‐1 in PD effluents, the prevalence of HIVDRMs was 62.5% (5/8) compared to 7.7% (4/52) among those with undetectable HIV‐1 ( p = 0.001) with non‐nucleoside reverse transcriptase inhibitor (NNRTI) resistance mutations predominating. On Spearman's correlation analysis, high plasma HIV levels ( ρ = 0.649, p < 0.001), T‐cell CD4 count ( ρ = −0370, p < 0.004), serum creatinine ( ρ = −0.396, p < 0.002), and white blood cell count ( ρ = −0.294, p < 0.023) levels were significant factors correlated with the detection of HIV‐1 in PD effluents. Moreover, HIVDRMs presence ( ρ = 0.504, p < 0.001) particularly NNRTI resistance ( ρ = 0.504, p < 0.001) were also significantly correlated with detection of HIV‐1 in PD effluents. The presence of HIVDRMs, high plasma HIV viral load, and T‐cell CD4 count were correlated with HIV‐1 shedding into PD effluents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralViral LoadPeritoneal DialysisVirus SheddingMutationHumansMaleFemaleCross-Sectional StudiesMiddle AgedAdultPrevalenceRNA, ViralAnti-HIV AgentsKidney Failure, ChronicCD4 Lymphocyte Count

Stichwörter der Autor:innen

HIV mutationsHIV sheddingantiretroviral therapyend‐stage kidney failureperitoneal dialysis

Substanzen

RNA, ViralAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa.
  • Next Generation Sequencing Unit and Division of Virology, University of the Free State, Bloemfontein, South Africa.
  • Division of Nephrology, University of the Free State, Bloemfontein, South Africa.
  • Department of Health of the Free State, Bloemfontein, South Africa.
  • Department of Community Health, University of the Free State, Bloemfontein, South Africa.
  • Division of Virology, University of the Free State, Bloemfontein, South Africa.

ORCID-Profile: Teboho Mooko

Förderung

  • Thuthuka National Research Foundation (NRF)
  • Bill and Melinda Gates Foundation (BMGF)
  • CSIR-DSI Inter-bursary Support Programme (IBS)

Zitieren

APA

Mooko, T., Bisiwe, F. B., Chikobvu, P., Morobadi, M. D., Mofokeng, T. R. P., Nyaga, M. M., Kemp, G., Goedhals, D., & Ndlovu, K. C. Z. (2024). The prevalence of HIV resistance mutations and their influence on the shedding of HIV‐1 into peritoneal dialysis effluent. Journal of Medical Virology. https://doi.org/10.1002/jmv.29734

Vancouver

Mooko T, Bisiwe FB, Chikobvu P, Morobadi MD, Mofokeng TRP, Nyaga MM, et al. The prevalence of HIV resistance mutations and their influence on the shedding of HIV‐1 into peritoneal dialysis effluent. Journal of Medical Virology. 2024. doi:10.1002/jmv.29734

BibTeX
@article{Mooko2024,
  author = {Mooko, Teboho and Bisiwe, Feziwe Busiswa and Chikobvu, Perpertual and Morobadi, Molefi Daniel and Mofokeng, Thabiso Rafaki Petrus and Nyaga, Martin Munene and Kemp, Gabre and Goedhals, Dominique and Ndlovu, Kwazi Celani Zwakele},
  title = {The prevalence of HIV resistance mutations and their influence on the shedding of HIV‐1 into peritoneal dialysis effluent},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29734}
}
Kostenlos starten →